Literature DB >> 20636404

An investigation of adequate volume for the diagnosis of malignancy in pleural fluids.

S C Thomas1, L R R Davidson, M E McKean.   

Abstract

OBJECTIVE: The cytological examination of pleural effusions is an important investigation in the diagnosis of malignancy. Maximizing the chances of identifying malignant effusions is therefore desirable. Recent Royal College of Pathologists guidelines, based on the British Society for Clinical Cytology codes of practice, have suggested that a minimum of 20 ml of pleural fluid is required for diagnostic purposes. METHODS &
RESULTS: We examined 2155 pleural fluids received over a 6-year period in order to define a minimum required volume for adequacy. By examining the plateau phase of a graph of threshold volumes for initial samples received for each patient (n =1584) we determine that a minimum fluid volume of 25 ml is required and that more than 50 ml does not improve sensitivity.
CONCLUSION: Between 25 and 50 ml of fluid are required for the adequate assessment of pleural effusions for malignancy.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20636404     DOI: 10.1111/j.1365-2303.2010.00786.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  6 in total

1.  Year in review 2011: respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imaging.

Authors:  José M Porcel; Chi Chiu Leung; Marcos I Restrepo; Pyng Lee
Journal:  Respirology       Date:  2012-04       Impact factor: 6.424

2.  Comparison of cytology, chest computed and positron emission tomography findings in malignant pleural effusion from lung cancer.

Authors:  Clement Brun; Pierre Gay; Michele Cottier; Georgia Karpathiou; Arnaud Patoir; Oliviet Tiffet; Fabrice-Guy Barral; Jean-Michel Vergnon; Marios E Froudarakis
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

3.  A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center.

Authors:  Yan-Li Zhu; Wen-Hao Ren; Qian Wang; Hai-Zhu Jin; Yi-Yi Guo; Dong-Mei Lin
Journal:  Diagn Pathol       Date:  2022-07-02       Impact factor: 3.196

4.  Adequacy of pleural fluid cytology for comprehensive molecular analysis of lung adenocarcinoma: Experience of a large health-care system.

Authors:  Siddhartha Dilip Dalvi; Karen Chau; Sujata Sajjan; Baidarbhi Chakraborty; Priyanka Karam; Seema Khutti; Cecilia Gimenez; Kasturi Das
Journal:  Cytojournal       Date:  2022-02-04       Impact factor: 2.091

5.  Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array.

Authors:  Till Braunschweig; Joon-Yong Chung; Chel Hun Choi; Hanbyoul Cho; Qing-Rong Chen; Ran Xie; Candice Perry; Javed Khan; Stephen M Hewitt
Journal:  Diagn Pathol       Date:  2015-05-29       Impact factor: 2.644

6.  The minimum volume of pleural fluid required to diagnose malignant pleural effusion: A retrospective study.

Authors:  Huimin Wu; Rahul Khosla; Prashant K Rohatgi; Suman S Chauhan; Edina Paal; Wen Chen
Journal:  Lung India       Date:  2017 Jan-Feb
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.